Revenue is key but the pink market is very unreliable. Example DXT* Pink limited, Delinquent-Sec, Chap-11 yet trading over 2 pennies. Such is the discourse of OTC. In my observation few will qualify-pass the audit and if Onci is producing revenue as projected then probably so. I do agree with you the translucent-delayed audit is a strain.